| DRUG - Bright Minds Biosciences Inc Ordinary Shares (Healthcare: Biotechnology) | Projected Earnings Date: 0000-02-29 (Delayed quote data 2026-02-10) |
|
|
|||||||||||||||||
|
|
|
| Company Profile | |
| Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatry disorders, epilepsy and pain. The company has a portfolio of next generation serotonin agonists designed to precisely target abnormalities in neurocircuitry that lead to dysfunctional behaviors. It is developing targeted therapies with the potential to improve the treatment of mental health and neurological disorders through the use of serotonergic compounds leveraging its scientific and drug development expertise to bring forward the next generation of safe and efficacious drugs. | |
| Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. |